- Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
- Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
- Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
- Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
- Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
- Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
- Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
- Lifecore Biomedical Provides Business Update
- Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
- Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
More ▼
Key statistics
As of last trade, Lifecore Biomedical Inc (LFCR:NSQ) traded at 6.41, 55.08% above the 52 week low of 4.13 set on May 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.42 |
---|---|
High | 6.46 |
Low | 6.40 |
Bid | 6.39 |
Offer | 6.42 |
Previous close | 6.46 |
Average volume | 145.85k |
---|---|
Shares outstanding | 30.55m |
Free float | 29.16m |
P/E (TTM) | -- |
Market cap | 197.33m USD |
EPS (TTM) | -2.12 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 14:58 BST.
More ▼